Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KADCYLA vs KETOPROFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

KADCYLA vs KETOPROFEN: Safety Overview

Metric KADCYLA KETOPROFEN
Total FAERS Reports 150 5,550
Deaths Reported 37 393
Death Rate 24.7% 7.1%
Hospitalizations 44 2,947
Average Patient Age 53.5 yrs 47.9 yrs
% Female Patients N/A 61.9%
FDA Approval Date N/A Dec 10, 1997
Manufacturer N/A Allegis Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued